Clinical studies have observed that plasma MMP-2 levels in ICH patients correlate with cerebral edema severity and neurological outcome (Ke et al., 2007; Yu et al., 2023), suggesting its involvement in acute injury processes. Here, MMP2 is linked to brain edema.